We next examined the hypothesis that genetic reconstitution of hepatic RGS16 in the context of Arg2 overexpression would reverse the improvements in hepatic steatosis, inflammation and insulin and glucose intolerance observed in Arg2-treated db/db mice. The gene discussed is ARG2; the disease is fatty liver disease.